{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:47:53Z","timestamp":1772182073483,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The effectiveness of mitomycin C (MMC) in trabeculectomy has long been established. The aim of this review is to evaluate the efficacy and safety of adjunctive agents in tube shunt drainage device surgery for glaucoma or ocular hypertension, since controversy still exists regarding their benefit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched CENTRAL, PubMed, Embase, Web of Science, Scopus, and BASE for RCTs, which have used adjuvant antimetabolites\u2014either MMC or 5-Fluorouracil (5-FU)\u2014and\/or anti-vascular endothelial growth factors (anti-VEGF) agents. The main outcome was IOP reduction at 12 months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten studies met our inclusion criteria. Nine used the Ahmed Glaucoma Valve (AGV) implant, while the double-plate Molteno implant was used in one study. Four studies used MMC. The remaining six studies used an anti-VEGF drug \u2013 either bevacizumab, ranibizumab or conbercept.<\/jats:p>\n                <jats:p>Only one MMC-study reported a significant difference in the IOP reduction between groups at 12 months, favouring the MMC group (55% and 51%; p\u2009&lt;\u20090.01). A significant difference was also reported by two out of five bevacizumab-studies, both favouring the bevacizumab group (55% and 51%, p\u2009&lt;\u20090.05; 58% and 27%, p\u2009&lt;\u20090.05), with the highest benefit seen in neovascular glaucoma cases, especially when panretinal photocoagulation (PRP) was also used. Neither ranibizumab nor conbercept were found to produce significant differences between groups regarding IOP reduction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is no high-quality evidence to support the use of MMC in tube shunt surgery. As for anti-VEGF agents, specifically bevacizumab, significant benefit seems to exist in neovascular glaucoma patients, especially if combined with PRP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-024-06476-z","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T09:02:23Z","timestamp":1713949343000},"page":"3273-3286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The efficacy of adjunctive mitomycin C and\/or anti-VEGF agents on glaucoma tube shunt drainage device surgeries: a systematic review"],"prefix":"10.1007","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5154-881X","authenticated-orcid":false,"given":"Raquel","family":"Figueiredo","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-816X","authenticated-orcid":false,"given":"Joao","family":"Barbosa-Breda","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"issue":"11","key":"6476_CR1","doi-asserted-by":"publisher","first-page":"e11686","DOI":"10.7759\/cureus.11686","volume":"12","author":"K Allison","year":"2020","unstructured":"Allison K, Patel D, Alabi O (2020) Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus 12(11):e11686. https:\/\/doi.org\/10.7759\/cureus.11686","journal-title":"Cureus"},{"key":"6476_CR2","doi-asserted-by":"publisher","unstructured":"Burr J, Azuara-Blanco A, Avenell A, Tuulonen A (2012) Medical versus surgical interventions for open angle glaucoma. The Cochrane database of systematic reviews (9):CD004399. https:\/\/doi.org\/10.1002\/14651858.CD004399.pub3","DOI":"10.1002\/14651858.CD004399.pub3"},{"issue":"8","key":"6476_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/IJG.0000000000001011","volume":"27","author":"J Barbosa-Breda","year":"2018","unstructured":"Barbosa-Breda J, Gon\u00e7alves-Pinho M, Santos JV, Rocha-Sousa A, Abeg\u00e3o-Pinto L, Stalmans I, Freitas A (2018) Trends in Glaucoma Surgical Procedures in Portugal: A 16-Year Nationwide Study (2000\u20132015). J Glaucoma 27(8):682\u2013686. https:\/\/doi.org\/10.1097\/IJG.0000000000001011","journal-title":"J Glaucoma"},{"issue":"3","key":"6476_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ophtha.2019.10.002","volume":"127","author":"SJ Gedde","year":"2020","unstructured":"Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt JD (2020) Treatment Outcomes in the Primary Tube Versus Trabeculectomy study after 3 years of follow-up. Am J Ophthalmol 127(3):333\u2013345. https:\/\/doi.org\/10.1016\/j.ophtha.2019.10.002","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"6476_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/01.icu.0000193080.55240.7e","volume":"17","author":"KS Schwartz","year":"2006","unstructured":"Schwartz KS, Lee RK, Gedde SJ (2006) Glaucoma drainage implants: a critical comparison of types. Curr Opin Ophthalmol 17(2):181\u2013189. https:\/\/doi.org\/10.1097\/01.icu.0000193080.55240.7e","journal-title":"Curr Opin Ophthalmol"},{"key":"6476_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajo.2017.01.003","volume":"176","author":"PG Christakis","year":"2017","unstructured":"Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK (2017) Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study. Am J Ophthalmol 176:118\u2013126. https:\/\/doi.org\/10.1016\/j.ajo.2017.01.003","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"6476_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jcp.1041040305","volume":"104","author":"RM Wohlhueter","year":"1980","unstructured":"Wohlhueter RM, McIvor RS, Plagemann PG (1980) Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J Cell Physiol 104(3):309\u2013319. https:\/\/doi.org\/10.1002\/jcp.1041040305","journal-title":"J Cell Physiol"},{"issue":"1","key":"6476_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coph.2012.10.008","volume":"13","author":"A Lockwood","year":"2013","unstructured":"Lockwood A, Brocchini S, Khaw PT (2013) New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery. Curr Opin Pharmacol 13(1):65\u201371. https:\/\/doi.org\/10.1016\/j.coph.2012.10.008","journal-title":"Curr Opin Pharmacol"},{"key":"6476_CR9","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019). Cochrane Handbook for Systematic Reviews of Interventions Chichester, United Kingdom","DOI":"10.1002\/9781119536604"},{"key":"6476_CR10","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF (2019) Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"6476_CR11","first-page":"240","volume":"4","author":"L Cantor","year":"1998","unstructured":"Cantor L, Burgoyne J, Sanders S, Bhavnani V, Hoop J, Brizendine E (1998) The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma 4:240\u2013246","journal-title":"J Glaucoma"},{"key":"6476_CR12","first-page":"1237","volume":"6","author":"K Fanxue","year":"2017","unstructured":"Fanxue K, Xiang M, Songtao F, Jianmin L, Xiuhong QIN, Jiyang Z (2017) Efficacy of intravitreal lucentis or conbercept injection combined with ahmed glaucoma valve implantation for treatment of neovascular glaucoma. J Jilin Univ (Medicine Edition) 6:1237\u20131242","journal-title":"J Jilin Univ (Medicine Edition)"},{"issue":"7","key":"6476_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/IJG.0b013e3181efbea5","volume":"20","author":"RA Mahdy","year":"2011","unstructured":"Mahdy RA (2011) Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma. J Glaucoma 20(7):458\u2013463. https:\/\/doi.org\/10.1097\/IJG.0b013e3181efbea5","journal-title":"J Glaucoma"},{"issue":"9","key":"6476_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/IJG.0b013e318259aec4","volume":"22","author":"RA Mahdy","year":"2013","unstructured":"Mahdy RA, Nada WM, Fawzy KM, Alnashar HY, Almosalamy SM (2013) Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma. J Glaucoma 22(9):768\u2013772. https:\/\/doi.org\/10.1097\/IJG.0b013e318259aec4","journal-title":"J Glaucoma"},{"issue":"4","key":"6476_CR15","doi-asserted-by":"publisher","first-page":"CD011875","DOI":"10.1002\/14651858.CD011875.pub2","volume":"4","author":"VHX Foo","year":"2019","unstructured":"Foo VHX, Htoon HM, Welsbie DS, Perera SA (2019) Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma. Cochrane Database Syst Rev 4(4):CD011875. https:\/\/doi.org\/10.1002\/14651858.CD011875.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6476_CR16","doi-asserted-by":"publisher","first-page":"7672485","DOI":"10.1155\/2017\/7672485","volume":"2017","author":"J Kwon","year":"2017","unstructured":"Kwon J, Sung KR (2017) Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages. J Ophthalmol 2017:7672485. https:\/\/doi.org\/10.1155\/2017\/7672485","journal-title":"J Ophthalmol"},{"key":"6476_CR17","doi-asserted-by":"publisher","first-page":"1645269","DOI":"10.1155\/2017\/1645269","volume":"2017","author":"M Slabaugh","year":"2017","unstructured":"Slabaugh M, Salim S (2017) Use of Anti-VEGF Agents in Glaucoma Surgery. J Ophthalmol 2017:1645269. https:\/\/doi.org\/10.1155\/2017\/1645269","journal-title":"J Ophthalmol"},{"key":"6476_CR18","first-page":"002897","volume":"1","author":"M Wilkins","year":"2005","unstructured":"Wilkins M, Indar A, Wormald R (2005) Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 1:002897","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6476_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00417-006-0415-2","volume":"245","author":"A Alsheikheh","year":"2007","unstructured":"Alsheikheh A, Klink J, Klink T, Steffen H, Grehn F (2007) Long-term results of surgery in childhood glaucoma. Graefes Arch Clin Exp Ophthalmol 245(2):195\u2013203. https:\/\/doi.org\/10.1007\/s00417-006-0415-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"6476_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ophtha.2010.01.016","volume":"117","author":"GS Ang","year":"2010","unstructured":"Ang GS, Crowston JG, Wells AP (2010) Pediatric Ahmed valves. Ophthalmology 117(6):1277\u20131278. https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.016","journal-title":"Ophthalmology"},{"issue":"7","key":"6476_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/IJG.0000000000001881","volume":"30","author":"V Promelle","year":"2021","unstructured":"Promelle V, Lyons CJ (2021) Long-term Results of Ahmed Valve Implantation With Mitomycin-C in Pediatric Glaucoma. J Glaucoma 30(7):596\u2013605. https:\/\/doi.org\/10.1097\/IJG.0000000000001881","journal-title":"J Glaucoma"},{"key":"6476_CR22","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.ophtha.2009.03.030","volume":"10","author":"F Al-Mobarak","year":"2009","unstructured":"Al-Mobarak F, Khan AO (2009) Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C. Ophthalmology 10:1862\u20131865. https:\/\/doi.org\/10.1016\/j.ophtha.2009.03.030","journal-title":"Ophthalmology"},{"issue":"5","key":"6476_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/archopht.1983.01040010795021","volume":"101","author":"EM Addicks","year":"1983","unstructured":"Addicks EM, Quigley HA, Green WR, Robin AL (1983) Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 101(5):795\u2013798. https:\/\/doi.org\/10.1001\/archopht.1983.01040010795021","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"6476_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/IJG.0000000000000256","volume":"25","author":"S Yazdani","year":"2016","unstructured":"Yazdani S, Mahboobipour H, Pakravan M, Doozandeh A, Ghahari E (2016) Adjunctive Mitomycin C or Amniotic Membrane Transplantation for Ahmed Glaucoma Valve Implantation: A Randomized Clinical Trial. J Glaucoma 25(5):415\u2013421. https:\/\/doi.org\/10.1097\/IJG.0000000000000256","journal-title":"J Glaucoma"},{"issue":"3","key":"6476_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s0039-6257(03)00038-9","volume":"48","author":"PJ Lama","year":"2003","unstructured":"Lama PJ, Fechtner RD (2003) Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol May-Jun 48(3):314\u2013346. https:\/\/doi.org\/10.1016\/s0039-6257(03)00038-9","journal-title":"Surv Ophthalmol May-Jun"},{"issue":"39","key":"6476_CR26","doi-asserted-by":"publisher","first-page":"e27326","DOI":"10.1097\/MD.0000000000027326","volume":"100","author":"HB Hwang","year":"2021","unstructured":"Hwang HB, Lee NY (2021) Effect of anti-vascular endothelial growth factor on the surgical outcome of neovascular glaucoma: An overview and meta-analysis. Medicine (Baltimore) 100(39):e27326. https:\/\/doi.org\/10.1097\/MD.0000000000027326","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"6476_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s0161-6420(82)34672-2","volume":"89","author":"RC Allen","year":"1982","unstructured":"Allen RC, Bellows AR, Hutchinson BT, Murphy SD (1982) Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 89(10):1181\u20131187. https:\/\/doi.org\/10.1016\/s0161-6420(82)34672-2","journal-title":"Ophthalmology"},{"issue":"3","key":"6476_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4103\/ijo.IJO_1591_20","volume":"69","author":"S Senthil","year":"2021","unstructured":"Senthil S, Dada T, Das T, Kaushik S, Puthuran GV, Philip R, Rani PK, Rao H, Singla S, Vijaya L (2021) Neovascular glaucoma - A review. Indian J Ophthalmol 69(3):525\u2013534. https:\/\/doi.org\/10.4103\/ijo.IJO_1591_20","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"6476_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/ICU.0b013e328323d519","volume":"20","author":"SR Sarkisian Jr","year":"2009","unstructured":"Sarkisian SR Jr (2009) Tube shunt complications and their prevention. Curr Opin Ophthalmol 20(2):126\u2013130. https:\/\/doi.org\/10.1097\/ICU.0b013e328323d519","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"6476_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/ICU.0000000000000034","volume":"25","author":"AK Bailey","year":"2014","unstructured":"Bailey AK, Sarkisian SR Jr (2014) Complications of tube implants and their management. Curr Opin Ophthalmol 25(2):148\u2013153. https:\/\/doi.org\/10.1097\/ICU.0000000000000034","journal-title":"Curr Opin Ophthalmol"},{"key":"6476_CR31","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2147\/OPTH.S368634","volume":"16","author":"S Dorairaj","year":"2022","unstructured":"Dorairaj S, Checo LA, Wagner IV, Ten Hulzen RD, Ahuja AS (2022) 24-Month Outcomes of Ahmed ClearPath\u00ae Glaucoma Drainage Device for Refractory Glaucoma. Clin Ophthalmol 16:2255\u20132262. https:\/\/doi.org\/10.2147\/OPTH.S368634","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"6476_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/IJG.0000000000001998","volume":"31","author":"MCJ Tan","year":"2022","unstructured":"Tan MCJ, Choy HYC, Koh Teck Chang V, Aquino MC, Sng CCA, Lim DKA, Loon SC, Chew Tec Kuan P (2022) Two-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma. J Glaucoma 31(6):449\u2013455. https:\/\/doi.org\/10.1097\/IJG.0000000000001998","journal-title":"J Glaucoma"},{"issue":"4","key":"6476_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/17434440.3.4.509","volume":"3","author":"RS Ayyala","year":"2006","unstructured":"Ayyala RS, Duarte JL, Sahiner N (2006) Glaucoma drainage devices: state of the art. Expert Rev Med Devices 3(4):509\u2013521. https:\/\/doi.org\/10.1586\/17434440.3.4.509","journal-title":"Expert Rev Med Devices"},{"issue":"12","key":"6476_CR34","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41433-021-01595-x","volume":"35","author":"ICF Pereira","year":"2021","unstructured":"Pereira ICF, van de Wijdeven R, Wyss HM, Beckers HJM, den Toonder JMJ (2021) Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions. Eye (Lond) 35(12):3202\u20133221. https:\/\/doi.org\/10.1038\/s41433-021-01595-x","journal-title":"Eye (Lond)"},{"key":"6476_CR35","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1007\/s12325-022-02207-0","volume":"39","author":"M Inatani","year":"2022","unstructured":"Inatani M, Kohama I, Chu A (2022) iStent Trabecular Micro-bypass Stent Implantation Combined with Phacoemulsification for Open-Angle Glaucoma: A 2-Year Post-marketing Surveillance Study in Japan. Adv Ther 39:4076\u20134093. https:\/\/doi.org\/10.1007\/s12325-022-02207-0","journal-title":"Adv Ther"},{"issue":"7","key":"6476_CR36","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/ceo.13191","volume":"46","author":"A Miraftabi","year":"2018","unstructured":"Miraftabi A, Nilforushan N, Darghahi M, Alemzadeh SA, Parsamanesh M, Yadgari, (2018) Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial. Clin Exp Ophthalmol 46(7):750\u2013756. https:\/\/doi.org\/10.1111\/ceo.13191","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"6476_CR37","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ophtha.2003.09.037","volume":"111","author":"VP Costa","year":"2004","unstructured":"Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES (2004) Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. Ophthalmology 111(6):1071\u20131076. https:\/\/doi.org\/10.1016\/j.ophtha.2003.09.037","journal-title":"Ophthalmology"},{"issue":"5","key":"6476_CR38","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s10792-021-01691-7","volume":"41","author":"R Zarei","year":"2021","unstructured":"Zarei R, Ghasempour M, Fakhraie G, Eslami Y, Mohammadi M, Hamzeh N, Sajadi F, Safizadeh M (2021) Ahmed glaucoma valve implantation with and without subconjunctival bevacizumab in refractory glaucoma. Int Ophthalmol 41(5):1593\u20131603. https:\/\/doi.org\/10.1007\/s10792-021-01691-7","journal-title":"Int Ophthalmol"},{"issue":"1","key":"6476_CR39","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/aos.12493","volume":"93","author":"ES Arcieri","year":"2015","unstructured":"Arcieri ES, Paula JS, Jorge R, Barella KA, Arcieri RS, Secches DJ, Costa VP (2015) Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up. Acta Ophthalmol 93(1):e1-6. https:\/\/doi.org\/10.1111\/aos.12493","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"6476_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1590\/s1807-59322009000600009","volume":"64","author":"X Zhang","year":"2009","unstructured":"Zhang X, Du S, Fan Q, Peng S, Yu M, Ge J (2009) Long-term surgical outcomes of primary congenital glaucoma in China. Clinics (Sao Paulo) 64(6):543\u2013551. https:\/\/doi.org\/10.1590\/s1807-59322009000600009","journal-title":"Clinics (Sao Paulo)"},{"key":"6476_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1590\/s1807-59322008000400002","volume":"4","author":"J Giampani Jr","year":"2008","unstructured":"Giampani J Jr, Borges-Giampani AS, Carani JC, Oltrogge EW, Susanna R Jr (2008) Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. Clinics (Sao Paulo) 4:421\u2013426. https:\/\/doi.org\/10.1590\/s1807-59322008000400002","journal-title":"Clinics (Sao Paulo)"},{"issue":"2","key":"6476_CR42","doi-asserted-by":"publisher","first-page":"007920","DOI":"10.1002\/14651858.CD007920.pub3","volume":"2","author":"A Simha","year":"2020","unstructured":"Simha A, Aziz K, Braganza A, Abraham L, Samuel P, Lindsley KB (2020) Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev 2(2):007920. https:\/\/doi.org\/10.1002\/14651858.CD007920.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06476-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06476-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06476-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T03:37:45Z","timestamp":1728358665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06476-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["6476"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06476-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors guarantee that they have confirmed that all practices performed in included studies, which involve human participants, are in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Regarding this systematic review, no approval was required from an authorized Medical Ethics Committee since this is a review of priorly published studies with no patient identifying information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors also ascertain that informed consent was confirmed to had been obtained from all individual participants involved in the included studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors hereby certify that there is not any actual or potential conflict of interest or unfair advantage, as they have no affiliations with or involvement in any organization or entity with any (non-)financial interest in the subject matter or material discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}